BNP Paribas Financial Markets’s 2seventy bio TSVT Stock Holding History

BNP Paribas Financial Markets’s Portfolio TSVT Stock Details TSVT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-9,378	Closed	-$46.3K	–	5675
2025 Q1	$46.3K	Sell	9,378 -2,695	-22%	-$8.56K	﹤0.01%	4315
2024 Q4	$35.5K	Buy	+12,073	New	+$49.5K	﹤0.01%	4558
2022 Q4	–	Sell	-53,357	Closed	-$776K	–	4613
2022 Q3	$776K	Buy	+53,357	New	+$792K	﹤0.01%	2674

Other funds holding TSVT

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

BNP Paribas Financial Markets's TSVT Position: Q2 2025 in Review

BNP Paribas Financial Markets sold out of 2seventy bio (TSVT) in Q2 2025, closing a stake of 9,378 shares — an estimated $46.3K sold.

BNP Paribas Financial Markets first reported a position in TSVT in Q3 2022 and held it in 3 quarters. The position peaked at $776K in Q3 2022. 2 funds tracked by Wall St. Rank hold TSVT as of Q2 2025.

BNP Paribas Financial Markets reported no remaining 2seventy bio position as of Q2 2025 after selling out during the quarter.
BNP Paribas Financial Markets sold 9,378 2seventy bio shares in Q2 2025, an estimated $46.3K.
BNP Paribas Financial Markets first reported a position in 2seventy bio in Q3 2022 and held it in 3 quarters.
BNP Paribas Financial Markets's 2seventy bio position peaked at $776K in Q3 2022.
2 funds tracked by Wall St. Rank held 2seventy bio as of Q2 2025.

Based on BNP Paribas Financial Markets's 13F filing for Q2 2025, filed 14 Aug 2025.